» Articles » PMID: 36615467

Ursolic Acid and Solasodine As Potent Anti-Mycobacterial Agents for Combating : An Anti-Inflammatory and In Silico Analysis

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Jan 8
PMID 36615467
Authors
Affiliations
Soon will be listed here.
Abstract

subspecies (MAP) infection in domestic livestock causes persistent diarrhea, weight loss, and death and is also a potential cause of Crohn's disease (CD) in humans; notably, treatments against MAP are insufficient, costly, and can cause adverse reactions. Hence, plant-derived bioactive constituents have been taken into consideration in this regard. Herein, we present the results of two bioactive constituents (Solasodine and Ursolic acid) that were evaluated for their safety and efficacy against MAP protein (Dephospho-Coenzyme A kinase (DPCK) by utilizing in vitro assays and different tools of in silico biology. The ADME/-test, the drug-likeness property test, pharmacophore modelling, and PASS prediction have proven that both the constituents have better binding capacities than the available antibiotic drugs used to target protein inhibition pathways. Through our observations, it can be inferred that these two phytochemicals can be adequately used to treat thereby combating inflammatory bowel disorders (IBD) of an autoimmune nature.

Citing Articles

Endophytic Fungus UJ3-2 from : Antibacterial Activity and Mechanism of Action against .

Liao F, He J, Li R, Hu Y Molecules. 2024; 29(20).

PMID: 39459217 PMC: 11510654. DOI: 10.3390/molecules29204850.


Bioprospective Role of and against Emerging Pathogen: Subspecies : A Review.

Bharath M, Gupta S, Vashistha G, Ahmad S, Singh S Molecules. 2023; 28(8).

PMID: 37110723 PMC: 10145132. DOI: 10.3390/molecules28083490.

References
1.
Masala S, Cossu D, Piccinini S, Rapini N, Mameli G, Manca Bitti M . Proinsulin and MAP3865c homologous epitopes are a target of antibody response in new-onset type 1 diabetes children from continental Italy. Pediatr Diabetes. 2015; 16(3):189-95. DOI: 10.1111/pedi.12269. View

2.
Swierczewska M, Lee K, Lee S . What is the future of PEGylated therapies?. Expert Opin Emerg Drugs. 2015; 20(4):531-6. PMC: 4908577. DOI: 10.1517/14728214.2015.1113254. View

3.
Drwal M, Banerjee P, Dunkel M, Wettig M, Preissner R . ProTox: a web server for the in silico prediction of rodent oral toxicity. Nucleic Acids Res. 2014; 42(Web Server issue):W53-8. PMC: 4086068. DOI: 10.1093/nar/gku401. View

4.
Chaubey K, Singh S, Gupta S, Singh M, Sohal J, Kumar N . Mycobacterium avium subspecies paratuberculosis - an important food borne pathogen of high public health significance with special reference to India: an update. Vet Q. 2017; 37(1):282-299. DOI: 10.1080/01652176.2017.1397301. View

5.
Holt M, Ju C . Mechanisms of drug-induced liver injury. AAPS J. 2006; 8(1):E48-54. PMC: 2751423. DOI: 10.1208/aapsj080106. View